A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae.

Blessing, E

A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae. [electronic resource] - The Journal of antimicrobial chemotherapy Jun 2005 - 1037-40 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0305-7453

10.1093/jac/dki128 doi


Animals
Anti-Bacterial Agents--therapeutic use
Apolipoproteins E--deficiency
Arteriosclerosis--drug therapy
Azithromycin--therapeutic use
Chlamydophila Infections--complications
Chlamydophila pneumoniae
Chronic Disease
Male
Mice